The real-world safety profile of SGLT2 inhibitors among adults 75 years or older: a retrospective, pharmacovigilance study

Authors: A Goldman, B Fishman, E Raschi, T Cukierman-Yaffe, R Dankner, I Ben-Zvi, E Maor

Published: 2022-10-15

DOI: 10.1093/eurheartj/ehac544.973

Source: Full article